Anne Flint
- Endocrinology, Diabetes and Metabolism top 0.2%
- Physiology top 0.5%
- Endocrine and Autonomic Systems top 0.2%
- Public Health, Environmental and Occupational Health top 0.5%
- Molecular Biology top 5%
- Co-authors
- Arne AstrupAnne RabenJens J. HolstJohn E. BlundellBirgitte SlothMads AxelsenLone Brinkmann SørensenChristoph Kapitza
- Topics
- Diabetes Treatment and Management (25 papers)Diet and metabolism studies (21 papers)Metabolism, Diabetes, and Cancer (17 papers)
- Partner nations
- DenmarkRussiaUnited Kingdom
In The Last Decade
Anne Flint
62 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Endocrinology, Diabetes and Metabolism 3.7k
- Physiology 3.5k
- Endocrine and Autonomic Systems 2.0k
- Public Health, Environmental and Occupational Health 1.8k
- Molecular Biology 1.6k
Countries citing papers authored by Anne Flint
This map shows the geographic impact of Anne Flint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Flint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Flint more than expected).
Fields of papers citing papers by Anne Flint
This network shows the impact of papers produced by Anne Flint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Flint. The network helps show where Anne Flint may publish in the future.
Co-authorship network of co-authors of Anne Flint
This figure shows the co-authorship network connecting the top 25 collaborators of Anne Flint. A scholar is included among the top collaborators of Anne Flint based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Flint. Anne Flint is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled studybreakdown → | 19 |
| 2 | 33 | |
| 3 | 170 | |
| 4 | 156 | |
| 5 | 144 | |
| 6 | 68 | |
| 7 | 58 | |
| 8 | 100 | |
| 9 | 30 | |
| 10 | 147 | |
| 11 | 59 | |
| 12 | 190 | |
| 13 | 107 | |
| 14 | 7 | |
| 15 | 196 | |
| 16 | 439 | |
| 17 | 70 | |
| 18 | 291 | |
| 19 | Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studiesbreakdown → | 1770 |
| 20 | 100 |
About Anne Flint
Anne Flint is a scholar working on Endocrine and Autonomic Systems, Endocrinology, Diabetes and Metabolism and Physiology, having authored 63 papers that have together received 8.6k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (25 papers), Diet and metabolism studies (21 papers) and Metabolism, Diabetes, and Cancer (17 papers). The work is most often cited by research in Endocrine and Autonomic Systems (2.0k citations), Endocrinology, Diabetes and Metabolism (3.7k citations) and Physiology (3.5k citations). Anne Flint has collaborated with scholars based in Denmark, Russia and United Kingdom. Frequent co-authors include Arne Astrup, Anne Raben, Jens J. Holst, John E. Blundell, Birgitte Sloth, Mads Axelsen, Lone Brinkmann Sørensen, Christoph Kapitza, Julie Hjerpsted and Mark Martens. Their work appears in journals such as The Lancet, Journal of Clinical Investigation and American Journal of Clinical Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.